In addition, miR-422a decreased the protein expression of BCL2L2 and KRAS while the mRNA levels remained unchanged, suggesting that miR-422a exhibited the anti-tumor effect via regulating BCL2L2 and KRAS protein expression in osteosarcoma cells. The gene discussed is BCL2L2; the disease is osteosarcoma.